N6037
奈立膦酸盐
≥97% (NMR), solid, bone resorption inhibitor
别名:
6-氨基-1-羟基亚己基双膦酸, 奈立膦酸, 奈立膦酸钠
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C6H17NO7P2
化学文摘社编号:
分子量:
277.15
UNSPSC Code:
51111800
PubChem Substance ID:
NACRES:
NA.77
MDL number:
产品名称
奈立膦酸盐, ≥97% (NMR), solid
SMILES string
NCCCCCC(O)(P(O)(O)=O)P(O)(O)=O
InChI
1S/C6H17NO7P2/c7-5-3-1-2-4-6(8,15(9,10)11)16(12,13)14/h8H,1-5,7H2,(H2,9,10,11)(H2,12,13,14)
InChI key
PUUSSSIBPPTKTP-UHFFFAOYSA-N
description
may contain <1% (w/w) inorganic salts
assay
≥97% (NMR)
form
solid
color
white
solubility
H2O: >5 mg/mL
storage temp.
2-8°C
Quality Level
相关类别
Biochem/physiol Actions
奈立膦酸是一种骨吸收抑制剂。它用于治疗成骨不全症。
奈立膦酸是一种骨吸收抑制剂。它用于治疗成骨不全症，一种“孤儿病”，其特征是骨骼极其脆弱以致于被成为“晶体骨骼疾病”。
signalword
Warning
hcodes
Hazard Classifications
Acute Tox. 4 Oral
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Gloves
法规信息
新产品
此项目有
Daniela Merlotti et al.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 26(3), 512-518 (2010-09-04)
Aminobisphosphonates actually represent the most common treatment for Paget disease of bone (PDB). In a previous study we demonstrated that either zoledronic acid (4 mg) or neridronate (200 mg) given as a single intravenous infusion showed a similar short-term efficacy
Evelina Maines et al.
Journal of bone and mineral metabolism, 30(4), 434-438 (2011-11-09)
Over recent years, several reports have been published on unusual cases of osteonecrosis of the jaw (ONJ) in adults using second- and third-generation nitrogen-containing bisphosphonates such as pamidronate, alendronate, risedronate and zoledronate, but no case has ever been reported either
Aino-Liisa Saari et al.
Molecules (Basel, Switzerland), 17(9), 10928-10945 (2012-09-14)
Aminobisphosphonates, e.g., alendronate and neridronate, are a well known class of molecules used as drugs for various bone diseases. Although these molecules have been available for decades, a detailed understanding of their most important physicochemical properties under comparable conditions is
Massimo Varenna et al.
Rheumatology (Oxford, England), 52(3), 534-542 (2012-12-04)
Complex regional pain syndrome type I (CRPS-I) is a severely disabling pain syndrome for which no definite treatment has been established. The aim of this multi-centre, randomized, double-blind placebo-controlled trial was to test the efficacy of the amino-bisphosphonate neridronate in
Gian Luca Forni et al.
British journal of haematology, 158(2), 274-282 (2012-05-11)
Neridronate is a third generation bisphosphonate with established efficacy in metabolic bone disease. In this randomized, open-label study, 118 adults with β-thalassaemia and bone mineral density (BMD) Z scores ≤-2·0 were randomized 1:1-500 mg calcium with 400 international unis (iu)
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持